Eton Pharmaceuticals (ETON) Cash from Operations (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Cash from Operations data on file, last reported at 11551000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Operations fell 1409.93% year-over-year to 11551000.0; the trailing twelve-month figure through Dec 2025 stood at 10524000.0 (up 986.07% YoY), and the FY2025 full-year result was 10524000.0, up 986.07% from the prior year.
• Cash from Operations slipped to 11551000.0 in Q4 2025, from 12026000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 12026000.0 in Q3 2025 to a low of 11551000.0 in Q4 2025.
• A 5-year average of 920400.0 and a median of 1048000.0 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations soared 766.94% in 2022 and tumbled 1409.93% in 2025, its largest moves.
• Tracing ETON's Cash from Operations over 5 years: stood at 5117000.0 in 2021, then soared by 155.5% to 2840000.0 in 2022, then plunged by 86.37% to 387000.0 in 2023, then plunged by 297.67% to 765000.0 in 2024, then plunged by 1409.93% to 11551000.0 in 2025.
• Business Quant data shows ETON's Cash from Operations at 11551000.0 in Q4 2025, 12026000.0 in Q3 2025, and 7959000.0 in Q2 2025.